###begin article-title 0
###xml 65 73 <span type="species:ncbi:9606">patients</span>
C-reactive protein correlates with tissue oxygen availability in patients with stable COPD
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
###xml 343 344 343 344 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 397 399 397 399 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 442 443 442 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 540 542 540 542 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2x</sub>
###xml 664 666 664 666 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2x</sub>
Arterial oxygen tension, oxygen delivery to tissue, and systemic inflammation are recognized as pivotal factors in the progression of chronic obstructive pulmonary disease (COPD). However, interconnections between systemic inflammation and tissue oxygen availability are scantly investigated. Tissue oxygen availability depends on arterial PaO2, oxygen concentration, hemoglobin oxygen affinity (P50), and hemoglobin oxygen binding capacity (ceHb). As the integrated changes of those indices are summarized by oxygen extraction tension (PaO2x), the objective of this study was to explore the association between C-reactive protein (CRP) blood levels and either PaO2x or each of its determinants, in stable COPD.
###end p 2
###begin title 3
Materials and methods
###end title 3
###begin p 4
###xml 143 145 143 145 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2x</sub>
###xml 346 347 346 347 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 349 350 349 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 360 362 360 362 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 486 488 486 488 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2x</sub>
###xml 130 138 <span type="species:ncbi:9606">patients</span>
Blood CRP and oxygen status of arterial blood were measured at rest while breathing room air in 44 moderate to severe stable COPD patients. PaO2x was calculated along the shape of oxygen binding curve as the oxygen tension resulting from removal of 2.3 mmol of oxygen per liter of blood. Multiple linear regression analysis was performed with PaO2, ceHb, and P50 as independent variables, and CRP as the dependent variable, adjusting for age and sex. The analysis was repeated using PaO2x as a sole independent variable.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 51 52 51 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 60 61 60 61 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 68 70 68 70 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 125 126 125 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 151 153 151 153 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2x</sub>
###xml 200 201 200 201 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Multiple linear regression analysis indicated that ceHb, PaO2, and P50, were significant and independent predictors of CRP (R2 = 0.52, p < 0.0001). PaO2x alone was an even stronger predictor of CRP (R2 = 0.62, p < 0.0001).
###end p 6
###begin title 7
Conclusions
###end title 7
###begin p 8
###xml 281 289 <span type="species:ncbi:9606">patients</span>
These findings indicate that physiological determinants of tissue oxygen availability are independently associated with CRP blood levels. Thus, improvement of tissue oxygen availability is a central therapeutic option to modulate the severity of systemic inflammatory processes in patients with COPD.
###end p 8
###begin title 9
Introduction
###end title 9
###begin p 10
###xml 23 40 23 40 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1-copd-3-745">Agust&#237; et al 2003</xref>
###xml 106 125 106 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17-copd-3-745">Kawakami et al 1983</xref>
###xml 527 539 527 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32-copd-3-745">Wouters 2005</xref>
###xml 507 515 <span type="species:ncbi:9606">patients</span>
Systemic inflammation (Agusti et al 2003) together with arterial hypoxemia and oxygen delivery to tissue (Kawakami et al 1983) are known to influence the prognosis of chronic obstructive pulmonary disease (COPD). Nevertheless, whether systemic inflammatory process is primarily linked to the convective/diffusive process of oxygen transport from the lung to tissues or it is just a secondary phenomenon has not been well acknowledged yet, as the origin of systemic inflammation remains poorly understood in patients with COPD (Wouters 2005).
###end p 10
###begin p 11
###xml 168 185 168 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26-copd-3-745">Schols et al 1996</xref>
###xml 187 207 187 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8-copd-3-745">de Torres et al 2006</xref>
###xml 209 231 209 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3-copd-3-745">Broekhuizen et al 2006</xref>
###xml 233 255 233 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22-copd-3-745">Pinto-Plata et al 2006</xref>
###xml 447 464 447 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b10-copd-3-745">Filley et al 1968</xref>
###xml 466 485 466 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17-copd-3-745">Kawakami et al 1983</xref>
###xml 497 530 497 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3-copd-3-745">Broekhuizen and colleagues (2006)</xref>
###xml 582 583 582 583 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 643 674 643 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8-copd-3-745">de Torres and colleagues (2006)</xref>
###xml 752 753 752 753 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 141 149 <span type="species:ncbi:9606">patients</span>
###xml 333 341 <span type="species:ncbi:9606">patients</span>
###xml 593 601 <span type="species:ncbi:9606">patients</span>
Recently published papers have reported that increased C-reactive protein (CRP) blood levels mark the metabolic and functional impairment in patients with stable COPD (Schols et al 1996; de Torres et al 2006; Broekhuizen et al 2006; Pinto-Plata et al 2006). Previous studies have also documented that wasting syndrome occurs in COPD patients with elevated arteriovenous oxygen difference, as a result of low arterial and mixed venous oxygenation (Filley et al 1968; Kawakami et al 1983). However, Broekhuizen and colleagues (2006) found no difference in arterial oxygen tension (PaO2) between patients with normal and raised CRP levels, while de Torres and colleagues (2006) found that no more than 20% of the variability of CRP is accounted for by PaO2.
###end p 11
###begin p 12
###xml 162 170 162 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 172 189 172 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12-copd-3-745">Ghezzi et al 1991</xref>
###xml 239 258 239 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15-copd-3-745">Hartmann et al 2000</xref>
###xml 649 650 649 650 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 805 807 805 807 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2x</sub>
###xml 1002 1029 1002 1029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30-copd-3-745">Siggard-Andersen et al 1995</xref>
###xml 1138 1157 1138 1157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24-copd-3-745">Ringsted et al 1990</xref>
###xml 206 212 <span type="species:ncbi:9606">humans</span>
###xml 440 448 <span type="species:ncbi:9606">patients</span>
It is well acknowledged that hypoxia induces the synthesis of inflammatory cytokines and the expression of adhesion molecules in different cell types and tissues in vitro (Ghezzi et al 1991), as well as in humans exposed at high altitude (Hartmann et al 2000). We wondered whether the severity of systemic inflammation, as assessed by CRP blood levels, is instead associated with tissue hypoxia rather than with arterial hypoxemia alone in patients with COPD. To test this hypothesis, we explored the relationship between systemic inflammation, as assessed by CRP blood levels, and each single determinant of oxygen status of arterial blood, ie, PaO2, blood oxygen carrying capacity, and blood oxygen affinity. We also explored the relationship between CRP blood levels, and oxygen extraction tension (PaO2x), as this is a noninvasive measurement of peripheral oxygen availability, which summarizes the degree of compensation among arterial oxygen tension, blood oxygen carrying capacity and affinity (Siggard-Andersen et al 1995) and reflects changes of cardiac output, which may affect extraction ratio and mixed venous oxygen tension (Ringsted et al 1990).
###end p 12
###begin title 13
Methods
###end title 13
###begin p 14
###xml 282 300 282 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21-copd-3-745">Pauwels et al 2001</xref>
###xml 9 17 <span type="species:ncbi:9606">patients</span>
###xml 52 60 <span type="species:ncbi:9606">patients</span>
###xml 303 311 <span type="species:ncbi:9606">Patients</span>
All COPD patients, consecutively referred to our in-patients pulmonary rehabilitation center of Montescano, Italy from January 2004 to January 2006, were considered eligible for the present study. They had to meet the American Thoracic Society (ATS) criteria for diagnosis of COPD (Pauwels et al 2001). Patients were excluded if they had: 1) idiophatic or acquired bronchiectasis; 2) COPD exacerbations within the last 4 weeks; 3) diagnosed cardiovascular disease (coronary artery, peripheral vascular, or cerebrovascular disease); 4) systemic confounding inflammatory disease, such as rheumatoid arthritis, psoriatic arthritis, systemic vasculitis, polymyalgia rheumatica, Crohn's disease, or allergic complication of infections: eg, erythema nodosum, rheumatic fever; 5) malignancies.
###end p 14
###begin p 15
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
###xml 240 248 <span type="species:ncbi:9606">patients</span>
###xml 421 429 <span type="species:ncbi:9606">patients</span>
Patients had to be clinically stable at the time of examination (no exacerbation within the last 4 weeks) on a standard treatment regimen consisting of inhaled corticosteroids, and beta adrenergic, and/or anticholinergic drugs. None of the patients had to be on systemic corticosteroids. The presence of cardiovascular risk factors (hypertension, diabetes, hypercholesterolemia) was registered. It was also noted whether patients were currently smoking, and whether they were on long-term oxygen therapy (LTOT). The Medical Ethics Committee at our institution approved the study design and a written informed consent was obtained prior to the study.
###end p 15
###begin p 16
###xml 43 44 43 44 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 245 246 245 246 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 395 424 394 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23-copd-3-745">Quanjer and colleagues (1993)</xref>
###xml 461 463 460 462 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CO</sub>
###xml 590 598 589 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2-copd-3-745">ATS 1995</xref>
###xml 644 656 643 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7-copd-3-745">Cotes (1979)</xref>
Forced expiratory volume in one second (FEV1), forced vital capacity (FVC), inspiratory forced vital capacity (IVC), and total lung capacity (TLC) were determined using a Jaeger spirometer and body box (Masterlab, Jaeger, Wurzburg, Germany). FEV1 was also measured 15 minutes after four inhalations of salbutamol (400 mug) from a metered-dose inhaler. Predicted equations utilized were those of Quanjer and colleagues (1993). Carbon monoxide transfer factor (TLCO) was measured (Baires System, Biomedin, Padua, Italy) using the single breath method and according to the ATS recommendation (ATS 1995). Reference equations utilized were those of Cotes (1979).
###end p 16
###begin p 17
###xml 56 57 56 57 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</underline>
###xml 91 92 91 92 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">o</underline>
###xml 104 105 104 105 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</underline>
###xml 117 118 117 118 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e</underline>
###xml 143 159 143 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5-copd-3-745">Celli et al 2004</xref>
###xml 262 263 262 263 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 272 273 272 273 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 25 33 <span type="species:ncbi:9606">patients</span>
Functional status of the patients was assessed by BODE (body mass index, degree of airflow obstruction, dyspnea, and exercise capacity) index (Celli et al 2004). This is a multidimensional grading system based on: 1) the measurement of body mass index (BMI, Kg/m2); 2) FEV1, % predicted; 3) degree of dyspnea, measured with the modified Medical Research Council (MMRC) dyspnea scale; and 4) the evaluation of exercise tolerance, as reflected by the distance walked at the 6 minute walking test (6MWD).
###end p 17
###begin p 18
Fasting EDTA blood samples were collected, early in the morning (8:00-10:00 hours). CRP was measured in duplicate by high sensitivity turbidimetric immuno-assay (PETIA) (Dade Behring) with a lower detection limit of 0.5 mg/L.
###end p 18
###begin p 19
###xml 504 505 504 505 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 550 551 550 551 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 843 844 843 844 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 942 943 942 943 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 990 991 990 991 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1005 1006 1005 1006 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1043 1044 1043 1044 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1093 1094 1093 1094 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1336 1337 1336 1337 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1498 1499 1498 1499 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 1547 1548 1547 1548 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 1805 1807 1805 1807 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 1862 1864 1862 1864 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2x</sub>
###xml 1958 1959 1958 1959 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1965 1966 1965 1966 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2009 2051 2009 2051 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28-copd-3-745">Siggard-Andersen and Siggard-Andersen 1990</xref>
###xml 2112 2113 2112 2113 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2230 2258 2230 2258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29-copd-3-745">Siggaard-Andersen et al 1984</xref>
###xml 120 128 <span type="species:ncbi:9606">patients</span>
###xml 235 243 <span type="species:ncbi:9606">patients</span>
Arterial blood samples were gently drawn from the brachial artery using a dedicated preheparinized blood sampler, while patients were seated and breathing room air. Oxygen breathing was temporarily withdrawn for at least 30 minutes in patients under oxygen therapy. Immediately after sample collection, mixing, and removal of the first drops of blood, the acid-base and oxygen status were analyzed. Arterial negative logarithm of hydrogen ion concentration (pH) and arterial carbon dioxide tensions (PaCO2), together with arterial oxygen tension (PaO2) and the oximetry parameters were measured using a blood gas analyzer (ABL Model 700 System Radiometer, Copenhagen, Denmark). The following oximetry parameters were directly measured: 1) concentration of total hemoglobin in the blood (tHb), which includes all types of hemoglobin ie, oxy- (O2Hb), deoxy- (HHb), carboxy- (COHb), and meta-hemoglobin (MetHb); 2) arterial oxygen saturation (sO2) (ie, the ratio between the concentration of O2Hb and HHb + O2Hb); 3) fraction of oxyhemoglobin (FO2Hb) (ie, the ratio between the concentration of O2Hb and tHb); 4) fraction of carboxyhemoglobin (FCOHb) (ie, the ratio between concentration of COHb and tHb); 5) fraction of metahemoglobin (FMetHb) (ie, the ratio between concentration of MetHb and tHb); 6) total arterial oxygen content (ct O2) (ie, the sum of the concentration of hemoglobin-bound oxygen and the concentration of physically dissolved oxygen). The concentration of effective hemoglobin (ceHb) ie, the concentration of total hemoglobin (ctHb) corrected for fractions of carboxyhemoglobin (FCOHb) and metahemoglobin (FMetHb), which are unable to bind oxygen reversibly was calculated as a measurement of hemoglobin oxygen binding capacity. Both oxygen tension at half saturation (50%) of blood (P50), and oxygen extraction tension of arterial blood (PaO2x), were calculated by extrapolation along the shape of the oxygen binding curve on the log PaO2 - ctO2 diagram, by a dedicated computer program (Siggard-Andersen and Siggard-Andersen 1990). The shape of the curve was modeled on the basis of the PaO2 and the hemoglobin oxygen saturation fraction meas ured in the arterial blood, using a hyperbolic tangent function (Siggaard-Andersen et al 1984).
###end p 19
###begin title 20
Statistical analysis
###end title 20
###begin p 21
###xml 77 78 77 78 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 80 81 80 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 91 93 91 93 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 255 257 255 257 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2x</sub>
The relationship between CRP and the determinants of oxygen extractivity (PaO2, ceHb, and P50) was assessed by multiple linear regression analysis, adjusting for age and sex. The same analysis was carried out to assess the relationship between CRP and PaO2x, the latter being considered as a comprehensive index of oxygen availability. Descriptive statistics are expressed as mean, standard deviation (SD) or median and interquartile range (IQR). A p value <0.05 was considered statistically significant.
###end p 21
###begin title 22
Results
###end title 22
###begin p 23
###xml 313 321 313 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1-copd-3-745">Figure 1</xref>
###xml 521 528 521 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1-copd-3-745">Table 1</xref>
###xml 25 33 <span type="species:ncbi:9606">patients</span>
###xml 288 296 <span type="species:ncbi:9606">patients</span>
###xml 335 343 <span type="species:ncbi:9606">patients</span>
###xml 399 407 <span type="species:ncbi:9606">patients</span>
###xml 412 415 <span type="species:ncbi:9606">men</span>
###xml 423 428 <span type="species:ncbi:9606">women</span>
###xml 542 550 <span type="species:ncbi:9606">patients</span>
A hundred and fifty-four patients with COPD were assessed for eligibility, and 101 of them were excluded from the analysis because they had either concurrent inflammatory disease or diagnosed cardiovascular disease that may raise CRP blood levels. The reasons and the numbers of excluded patients are detailed in Figure 1. Nine of the patients refused to participate in the study, therefore 44 COPD patients (34 men and 10 women) were recruited in the study. Anthropometric and functional characteristics are reported in Table 1. Most of the patients (41%) were in GOLD stage IV, 93% were exsmokers, and 1rrent smokers, with a smoking history of 61 +/- 31(mean +/- SD) pack-years.
###end p 23
###begin p 24
###xml 55 63 <span type="species:ncbi:9606">patients</span>
###xml 83 91 <span type="species:ncbi:9606">patients</span>
###xml 121 129 <span type="species:ncbi:9606">patients</span>
###xml 281 289 <span type="species:ncbi:9606">patients</span>
Cardiovascular risk factors were present in 64% of the patients. Out of 44, 43% of patients was on LTOT. The majority of patients (96%) was on inhaled corticosteroid therapy, none of them assumed systemic steroids at the time of the study; 61% was on antihypertensive drugs; 7% of patients was on statins.
###end p 24
###begin p 25
###xml 75 83 <span type="species:ncbi:9606">patients</span>
The performance status as assessed by BODE index was scored >/=8 in 16% of patients, indicating a severely impaired performance. The median interquartile range CRP mg/L was 4.3 (3.0-8.4).
###end p 25
###begin p 26
###xml 51 52 51 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 108 109 108 109 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 116 118 116 118 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 137 138 137 138 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 163 170 163 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2-copd-3-745">Table 2</xref>
###xml 288 289 288 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 297 298 297 298 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 305 307 305 307 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 328 330 328 330 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2x</sub>
###xml 333 334 333 334 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 360 367 360 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3-copd-3-745">Table 3</xref>
###xml 401 403 401 403 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2x</sub>
Multiple linear regression analysis indicates that ceHb, were independently and significantly associated PaO2, and P50 with blood CRP, (R2 = 0.52, p < 0.0001). In Table 2, beta coefficients, standard errors, t values and p values are reported. An even stronger association was found when ceHb, PaO2, and P50 were replaced by PaO2x (R2 = 0.62, p < 0.0001), see Table 3. The specific contribution of PaO2x to CRP variability was 56%.
###end p 26
###begin title 27
Discussion
###end title 27
###begin p 28
###xml 125 142 125 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1-copd-3-745">Agust&#237; et al 2003</xref>
###xml 144 161 144 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26-copd-3-745">Schols et al 1996</xref>
###xml 163 177 163 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b11-copd-3-745">Gan et al 2004</xref>
###xml 228 250 228 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3-copd-3-745">Broekhuizen et al 2006</xref>
###xml 252 269 252 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26-copd-3-745">Schols et al 1996</xref>
###xml 271 293 271 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22-copd-3-745">Pinto-Plata et al 2006</xref>
###xml 105 113 <span type="species:ncbi:9606">patients</span>
###xml 340 348 <span type="species:ncbi:9606">patients</span>
C-reactive protein is recognized as a biomarker of the systemic inflammatory response that characterizes patients with COPD (Agusti et al 2003; Schols et al 1996; Gan et al 2004). The results of our study confirm previous data (Broekhuizen et al 2006; Schols et al 1996; Pinto-Plata et al 2006) that CRP levels are increased in stable COPD patients, and provide the novel finding of a strong association between reduced "oxygen extractivity" and CRP blood level in stable disease condition.
###end p 28
###begin p 29
###xml 54 93 54 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30-copd-3-745">Siggaard-Andersen and colleagues (1995)</xref>
###xml 349 351 349 351 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2x</sub>
###xml 354 382 354 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29-copd-3-745">Siggaard-Andersen et al 1984</xref>
###xml 388 390 388 390 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2x</sub>
###xml 660 679 660 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24-copd-3-745">Ringsted et al 1990</xref>
###xml 699 701 699 701 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2x</sub>
###xml 829 856 829 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30-copd-3-745">Siggard-Andersen et al 1995</xref>
The term "oxygen extractivity" originally proposed by Siggaard-Andersen and colleagues (1995) indicates the property which allows tissues to extract the usual amount of oxygen without a fall in oxygen tension below the usual venous level. This is measured along the shape of the oxygen binding curve, and quantified as oxygen extraction tension (PaO2x) (Siggaard-Andersen et al 1984). PaO2x describes disturbances in oxygen availability depending on arterial oxygen tension, hemoglobin oxygen affinity and hemoglobin oxygen binding capacity, and reflects adjustments of cardiac output to maintain normal venous oxygen tension, if oxygen consumption is normal (Ringsted et al 1990). Thus, we take PaO2x as a convenient estimation of the bio-energetic process of the convective/diffusive oxygen transport from the lung to tissues (Siggard-Andersen et al 1995).
###end p 29
###begin p 30
###xml 55 58 55 58 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2x,</sub>
###xml 109 151 109 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28-copd-3-745">Siggard-Andersen and Siggard-Andersen 1990</xref>
###xml 361 362 361 362 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 384 385 384 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 391 393 391 393 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
The finding of a strong association between CRP and PaO2x, as assessed by the Siggaard-Andersen's algorithm (Siggard-Andersen and Siggard-Andersen 1990), suggests a pathogenic link between systemic inflammation and reduced oxygen extractivity at tissue level. This result is also supported by the finding of a significant and independent predictive value of PaO2 after adjustment for ceHb, P50, age, and sex.
###end p 30
###begin p 31
###xml 45 76 45 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8-copd-3-745">de Torres and colleagues (2006)</xref>
###xml 134 135 134 135 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 195 197 195 197 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2x</sub>
###xml 264 265 264 265 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 155 163 <span type="species:ncbi:9606">patients</span>
These data are not in contrast with those of de Torres and colleagues (2006), who report that CRP blood levels best correlate with PaO2 in 130 stable COPD patients. Furthermore, dependence of PaO2x on hemoglobin oxygen affinity, hemoglobin oxygen capacity, and PaO2 forwards the idea that oxygenation state of hemoglobin, and total number of hemoglobin molecules play a regulatory role on peripheral oxygen availability, together with arterial hypoxemia.
###end p 31
###begin p 32
###xml 18 35 18 35 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b10-copd-3-745">Filley et al 1968</xref>
###xml 37 55 37 55 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4-copd-3-745">Burrows et al 1972</xref>
###xml 414 431 414 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26-copd-3-745">Schols et al 1996</xref>
###xml 563 600 563 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13-copd-3-745">Gonz&#225;lez-Alonso and colleagues (2006)</xref>
###xml 667 668 667 668 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 786 787 786 787 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1216 1233 1216 1233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6-copd-3-745">Chance et al 1986</xref>
###xml 1235 1253 1235 1253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25-copd-3-745">Sauleda et al 1998</xref>
###xml 77 85 <span type="species:ncbi:9606">patients</span>
###xml 1164 1172 <span type="species:ncbi:9606">patients</span>
Previous studies (Filley et al 1968; Burrows et al 1972) indicated that COPD patients with a low cardiac output pattern have more problems with tissue oxygenation during exercise than is apparent from their arterial hypoxemia at rest, and that tissue hypoxia may account at least in part for muscle weakness and impaired performance during physical activity. This issue has been further addressed by Schols et al (Schols et al 1996) who suggested the notion of a link between CRP and impaired exercise capacity and distress due to respiratory symptoms. Moreover, Gonzalez-Alonso and colleagues (2006) reported that local regulation of skeletal muscle blood flow and O2 delivery primarily senses alterations in the oxygenation state of hemoglobin, suggesting an important role of blood O2 gradients in muscle microcirculatory control. Our findings further emphasize these concepts. They deserve further attention to unravel molecular responses elicited by tissue hypoxia within the lung, the systemic circulation, and the muscles, such as the hypothesized metabolic uncoupling between the citric acid cycle and the electron transport chain at mitochondria level in patients with COPD and chronic respiratory failure (Chance et al 1986; Sauleda et al 1998).
###end p 32
###begin p 33
###xml 16 36 16 36 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19-copd-3-745">Kishimoto et al 1989</xref>
###xml 38 52 38 52 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16-copd-3-745">Jakobsson 1990</xref>
###xml 54 72 54 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20-copd-3-745">Maltais et al 1996</xref>
###xml 74 87 74 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b34-copd-3-745">Yu et al 1998</xref>
###xml 89 101 89 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b27-copd-3-745">Semenza 2000</xref>
###xml 103 124 103 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31-copd-3-745">Takabatake et al 2000</xref>
###xml 126 144 126 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9-copd-3-745">Engelen et al 2000</xref>
###xml 146 163 146 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18-copd-3-745">Keller et al 2001</xref>
Recent studies (Kishimoto et al 1989; Jakobsson 1990; Maltais et al 1996; Yu et al 1998; Semenza 2000; Takabatake et al 2000; Engelen et al 2000; Keller et al 2001) have begun to delineate pathophysiology of hypoxic chronic lung diseases in terms of changes in gene expression that are mediated by transcription factors like HIF1, tumor necrosis factor system and nuclear factor interleukin (IL)-6, among the others. As the pro-inflammatory cytokine IL-6 largely regulates plasma concentrations of CRP, the molecular mechanisms that link CRP blood levels and tissue hypoxia seem to be a crucial point for a better understanding of the origin of systemic inflammatory process in COPD.
###end p 33
###begin p 34
###xml 522 541 522 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15-copd-3-745">Hartmann et al 2000</xref>
###xml 997 1013 997 1013 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b33-copd-3-745">Yokoe et al 2003</xref>
###xml 567 575 <span type="species:ncbi:9606">patients</span>
###xml 854 862 <span type="species:ncbi:9606">patients</span>
Haagobian and colleagues (2006) documented the association between IL-6 mediated increase of CRP and either hypoxia, or exercise, or caloric deficit in normal subjects, who exercise at high altitude. Furthermore, in healthy subjects exposed at high altitude, a moderate increase of CRP levels is reported to follow the upregulation of both cytokine IL-6 and interleukin-1 receptor antagonist (IL-1ra), arguing for the onset of a low-grade acute phase response to an inflammatory stimulus such as hypoxia at high altitude (Hartmann et al 2000). Similarly, in our COPD patients the reported increase of rest blood CRP levels below the range expected for acute inflammation invites speculation on a low-grade chronic IL-6 release in response to chronic hypoxia. The decreased CRP levels and IL-6 and spontaneous production of IL-6 by monocytes by n-CPAP in patients with obstructive sleep apnea syndrome (OSAS) might provide another evidence supporting this idea in relation to intermittent hypoxia (Yokoe et al 2003).
###end p 34
###begin p 35
###xml 109 117 109 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1-copd-3-745">Figure 1</xref>
###xml 437 457 437 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8-copd-3-745">de Torres et al 2006</xref>
###xml 52 60 <span type="species:ncbi:9606">patients</span>
###xml 196 204 <span type="species:ncbi:9606">patients</span>
###xml 310 318 <span type="species:ncbi:9606">patients</span>
###xml 492 500 <span type="species:ncbi:9606">patients</span>
The exclusion from the analysis of about 2/3 of the patients with COPD according to the criteria detailed in Figure 1 could be regarded as a potential limitation of the study. However, out of 101 patients excluded from the analysis, 52 had a diagnosed cardiovascular disease. Therefore, the percentage of COPD patients showing the presence of cardiovascular risk factors or diseases (52%) does not differ from previously published data (de Torres et al 2006). Thus, we are confident that the patients included in the analysis were also representative of the general COPD population.
###end p 35
###begin title 36
Conclusion
###end title 36
###begin p 37
###xml 820 828 <span type="species:ncbi:9606">patients</span>
Our findings clearly indicate that systemic inflammation is strongly related to reduced oxygen extractivity, and presumably tissue hypoxia, throughout the interplay of either intrapulmonary oxygen transport and blood supply mechanisms, or systemic regulatory aspects of hemoglobin oxygen transport. Our data allow some speculation on how the responses to chronic exposure to low oxygen concentrations have evolved into adaptive mechanisms operating at tissue level. To the extent that under conditions of tissue hypoxia these responses also promote a systemic damage, COPD would become a key element boosting other systemic inflammatory processes. As a practical implication, the improvement of tissue oxygen availability becomes a central therapeutic option to modulate the severity of systemic inflammatory process in patients with COPD.
###end p 37
###begin title 38
Acknowledgments
###end title 38
###begin p 39
The authors thank the Respiratory Pathopsychology laboratory staff of Montescano Rehabilitation institute for technical assistance; Mrs. Alma Chiapponi for secretarial assistance, and Mrs. Jennifer Chesterfield for English editing assistance. The authors report no conflicts of interest in this work.
###end p 39
###begin title 40
References
###end title 40
###begin article-title 41
Systemic effects of chronic obstructive pulmonary disease
###end article-title 41
###begin article-title 42
Single-breath carbon monoxide diffusing capacity (transfer factor). Recommendations for a standard technique-1995 update
###end article-title 42
###begin article-title 43
Raised CRP levels mark metabolic and functional impairment in advanced COPD
###end article-title 43
###begin article-title 44
Patterns of cardiovascular dysfunction in chronic obstructive lung disease
###end article-title 44
###begin article-title 45
The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease
###end article-title 45
###begin article-title 46
Multiple controls of oxidative metabolism in living tissue as studied by phosphorus magnetic resonance
###end article-title 46
###begin article-title 47
###xml 86 94 <span type="species:ncbi:9606">patients</span>
C-Reactive protein levels and clinically important predictive outcomes in stable COPD patients
###end article-title 47
###begin article-title 48
###xml 71 79 <span type="species:ncbi:9606">patients</span>
Exercise-induced lactate increase in relation to muscles substrates in patients with chronic obstructive pulmonary disease
###end article-title 48
###begin article-title 49
Chronic obstructive bronchopulmonary disease. II. Oxygen transport in the two clinical types
###end article-title 49
###begin article-title 50
Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and meta-analysis
###end article-title 50
###begin article-title 51
###xml 75 80 <span type="species:ncbi:9606">human</span>
Hypoxia increases production of interleukin-1 and tumor necrosis factor by human mononuclear cells
###end article-title 51
###begin article-title 52
###xml 35 40 <span type="species:ncbi:9606">human</span>
Erythrocytes and the regulation of human skeletal muscle blood flow and oxygen delivery: role of erythrocyte count and oxygenation state of hemoglobin
###end article-title 52
###begin article-title 53
Cytokine response at high altitude: effects of exercise and antioxidants at 4300 m
###end article-title 53
###begin article-title 54
High altitude increases circulating Interleukin-6, Interleukin-1 receptor antagonist and C-reactive protein
###end article-title 54
###begin article-title 55
###xml 48 56 <span type="species:ncbi:9606">patients</span>
Skeletal muscles metabolites and fiber types in patients with advanced chronic obstructive pulmonary disease
###end article-title 55
###begin article-title 56
Relation of oxygen delivery, mixed venous oxygenation, and pulmonary hemodynamics to prognosis in chronic obstructive pulmonary disease
###end article-title 56
###begin article-title 57
###xml 47 52 <span type="species:ncbi:9606">human</span>
Transcriptional activation of the IL-6 gene in human contracting skeletal muscle: influence of muscle glycogen content
###end article-title 57
###begin article-title 58
The biology of interleukin-6
###end article-title 58
###begin article-title 59
###xml 109 117 <span type="species:ncbi:9606">patients</span>
Oxydative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD
###end article-title 59
###begin article-title 60
GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary
###end article-title 60
###begin article-title 61
###xml 22 30 <span type="species:ncbi:9606">patients</span>
C-reactive protein in patients with COPD, control smokers and non-smokers
###end article-title 61
###begin article-title 62
Standardized lung function testing
###end article-title 62
###begin article-title 63
###xml 90 91 90 91 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 182 190 <span type="species:ncbi:9606">patients</span>
Positive correlation between 'the arterial oxygen extraction tension' and mixed venous PaO2 but lack of correlation between 'the oxygen compensation factor' and cardiac output in 38 patients
###end article-title 63
###begin article-title 64
###xml 84 92 <span type="species:ncbi:9606">patients</span>
Cytochrome oxidase activity and mitochondrial gene expression in skeletal muscle of patients with chronic obstructive pulmonary disease
###end article-title 64
###begin article-title 65
###xml 119 127 <span type="species:ncbi:9606">patients</span>
Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease
###end article-title 65
###begin article-title 66
HIF-1 factor: mediator of physiological and pathophysiological responses to hypoxia
###end article-title 66
###begin article-title 67
The Oxygen status algorithm: a computer program for calculating and displaying pH, blood gas data
###end article-title 67
###begin article-title 68
###xml 68 73 <span type="species:ncbi:9606">human</span>
A mathematical model of the hemoglobin-oxygen dissociation curve of human blood and of the oxygen partial pressure as a function of temperature
###end article-title 68
###begin article-title 69
Oxygen status of arterial and mixed venous blood
###end article-title 69
###begin article-title 70
###xml 103 111 <span type="species:ncbi:9606">patients</span>
The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary disease
###end article-title 70
###begin article-title 71
Local and systemic inflammation in chronic obstructive pulmonary disease
###end article-title 71
###begin article-title 72
###xml 59 67 <span type="species:ncbi:9606">patients</span>
Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure
###end article-title 72
###begin article-title 73
Temporal, spatial and oxygen-regulated expression of hypoxia-inducible factor-1 in the lung
###end article-title 73
###begin p 74
###xml 22 34 <span type="species:ncbi:9606">participants</span>
Flow of eligible COPD participants through the analysis.
###end p 74
###begin p 75
###xml 0 6 0 6 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Notes:</bold>
###xml 27 41 27 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#182;</sup>
###xml 187 199 174 175 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#167;</sup>
Notes: Exclusion criteria: paragraph signCOPD exacerbations within the last 4 weeks; *Diagnosed cardiovascular disease (coronary artery, peripheral vascular, or cerebrovascular disease); section signSystemic inflammatory disease, such as rheumatoid arthritis, psoriatic arthritis, systemic vasculitis, polymyalgia rheumatica, Crohn's disease, or allergic complication of infections: eg, erythema nodosum, rheumatic fever, etc.
###end p 75
###begin p 76
###xml 47 55 <span type="species:ncbi:9606">patients</span>
Clinical and physiologic characteristics of 44 patients with stable COPD
###end p 76
###begin p 77
###xml 0 14 0 14 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Abbreviations:</bold>
###xml 165 166 165 166 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 284 285 284 285 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 391 392 391 392 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 431 432 431 432 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 462 464 462 464 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2x</sub>
###xml 494 496 494 496 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 532 533 532 533 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Abbreviations: BMI, body mass index; BODE, BMI, degree of airflow obstruction, dyspnea, and exercise capacity index; COPD, chronic obstructive pulmonary disease; FEV1, forced expiratory volume in one second; FCOHb, fraction of carboxyhemoglobin; FMetHb, fraction of metahemoglobin; FO2Hb, fraction of oxyhemoglobin; MMRC-D, scores on the Modified Medical Research Council dyspnea scale; PaCO2, arterial carbon dioxide tensions; PaO2, arterial oxygen tension; PaO2x, oxygen extraction tension; P50, oxygen half saturation tension; sO2, arterial oxygen saturation; tHb, total hemoglobin; 6MWD, distance walked in six minutes.
###end p 77
###begin p 78
Multiple linear regression analysis with CRP as the dependent variable
###end p 78
###begin p 79
###xml 0 5 0 5 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Note:</bold>
###xml 7 8 7 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Note: R2 = 0.52.
###end p 79
###begin p 80
###xml 0 14 0 14 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Abbreviations:</bold>
###xml 14 15 14 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 84 85 84 85 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 113 115 113 115 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
Abbreviations:ceHb, hemoglobin oxygen binding capacity; CRP, C-reactive protein; PaO2, arterial oxygen tension; P50, oxygen half saturation tension.
###end p 80
###begin p 81
Multiple linear regression analysis with CRP as the dependent variable
###end p 81
###begin p 82
###xml 0 5 0 5 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Note:</bold>
###xml 7 8 7 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Note: R2 = 0.62.
###end p 82
###begin p 83
###xml 0 14 0 14 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Abbreviations:</bold>
###xml 43 45 43 45 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2x</sub>
Abbreviations: CRP, C-reactive protein; PaO2x, oxygen extraction tension.
###end p 83

